Swiss National Bank’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Sell
80,800
-3,400
-4% -$75.6K ﹤0.01% 1903
2025
Q4
$2.18M Sell
84,200
-5,600
-6% -$133K ﹤0.01% 1833
2025
Q3
$2.31M Buy
89,800
+1,400
+2% +$34.4K ﹤0.01% 1787
2025
Q2
$2.11M Sell
88,400
-1,100
-1% -$27.7K ﹤0.01% 1786
2025
Q1
$2.22M Sell
89,500
-1,900
-2% -$45.5K ﹤0.01% 1697
2024
Q4
$1.72M Hold
91,400
﹤0.01% 1941
2024
Q3
$1.38M Hold
91,400
﹤0.01% 2071
2024
Q2
$2.61M Hold
91,400
﹤0.01% 1676
2024
Q1
$2.67M Hold
91,400
﹤0.01% 1681
2023
Q4
$3.08M Sell
91,400
-9,700
-10% -$284K ﹤0.01% 1598
2023
Q3
$3.1M Buy
101,100
+1,100
+1% +$39.6K ﹤0.01% 1568
2023
Q2
$4.01M Buy
100,000
+1,000
+1% +$41.3K ﹤0.01% 1443
2023
Q1
$4.04M Sell
99,000
-11,600
-10% -$461K ﹤0.01% 1399
2022
Q4
$4.27M Buy
110,600
+2,900
+3% +$141K ﹤0.01% 1421
2022
Q3
$5.73M Buy
107,700
+2,400
+2% +$133K ﹤0.01% 1197
2022
Q2
$6.14M Hold
105,300
﹤0.01% 1203
2022
Q1
$8.04M Buy
105,300
+7,500
+8% +$500K ﹤0.01% 1143
2021
Q4
$5.88M Buy
97,800
+600
+0.6% +$33.1K ﹤0.01% 1354
2021
Q3
$5.44M Buy
97,200
+1,400
+1% +$80.7K ﹤0.01% 1403
2021
Q2
$5.81M Buy
95,800
+1,500
+2% +$94.9K ﹤0.01% 1399
2021
Q1
$6.61M Buy
94,300
+2,500
+3% +$179K ﹤0.01% 1286
2020
Q4
$5.49M Buy
91,800
+1,100
+1% +$64.4K ﹤0.01% 1313
2020
Q3
$5.45M Buy
90,700
+1,600
+2% +$93K ﹤0.01% 1123
2020
Q2
$4.67M Buy
89,100
+16,300
+22% +$681K ﹤0.01% 1185
2020
Q1
$2.44M Buy
72,800
+1,100
+2% +$45.7K ﹤0.01% 1335
2019
Q4
$3.25M Buy
71,700
+1,800
+3% +$76.5K ﹤0.01% 1434
2019
Q3
$2.66M Buy
69,900
+1,000
+1% +$39.9K ﹤0.01% 1491
2019
Q2
$3M Sell
68,900
-6,000
-8% -$255K ﹤0.01% 1443
2019
Q1
$2.85M Buy
74,900
+2,500
+3% +$97.6K ﹤0.01% 1436
2018
Q4
$3.12M Buy
72,400
+2,600
+4% +$121K ﹤0.01% 1281
2018
Q3
$3.43M Hold
69,800
﹤0.01% 1368
2018
Q2
$2.24M Hold
69,800
﹤0.01% 1630
2018
Q1
$2.17M Hold
69,800
﹤0.01% 1579
2017
Q4
$3.19M Buy
69,800
+2,700
+4% +$107K ﹤0.01% 1341
2017
Q3
$2.52M Buy
67,100
+4,000
+6% +$161K ﹤0.01% 1459
2017
Q2
$3.01M Buy
63,100
+1,800
+3% +$83.5K ﹤0.01% 1325
2017
Q1
$2.79M Buy
61,300
+1,500
+3% +$64.8K ﹤0.01% 1358
2016
Q4
$1.93M Hold
59,800
﹤0.01% 1577
2016
Q3
$2.05M Sell
59,800
-2,100
-3% -$82.3K ﹤0.01% 1498
2016
Q2
$2.09M Buy
61,900
+800
+1% +$39.3K ﹤0.01% 1478
2016
Q1
$3.13M Buy
61,100
+14,000
+30% +$819K 0.01% 1149
2015
Q4
$3.62M Hold
47,100
0.01% 961
2015
Q3
$1.94M Buy
47,100
+6,300
+15% +$386K 0.01% 1332
2015
Q2
$2.88M Buy
40,800
+2,500
+7% +$197K 0.01% 1090
2015
Q1
$3.4M Buy
38,300
+500
+1% +$50.7K 0.01% 980
2014
Q4
$3.35M Buy
37,800
+1,000
+3% +$94.6K 0.01% 939
2014
Q3
$3.57M Buy
36,800
+2,600
+8% +$253K 0.01% 870
2014
Q2
$3.14M Buy
34,200
+2,900
+9% +$221K 0.01% 989
2014
Q1
$2.19M Buy
31,300
+7,400
+31% +$503K 0.01% 1158
2013
Q4
$1.37M Hold
23,900
0.01% 1291
2013
Q3
$1.15M Sell
23,900
-1,100
-4% -$40.1K ﹤0.01% 1360
2013
Q2
$725K Buy
+25,000
New +$723K ﹤0.01% 1653

Other funds holding PCRX